Intravenous ofatumumab treatment of multiple sclerosis and related disorders: An observational study
Sahla El Mahdaoui(Copenhagen University Hospital), Finn Sellebjerg(Danish Multiple Sclerosis Center), Melinda Magyari(University of Copenhagen), Malthe Faurschou Wandall‐Holm(Rigshospitalet), Jeppe Romme Christensen(Aarhus University Hospital)
Cited by 7
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209